COVID-19

News

EMA review finds AZ COVID-19 vaccine “safe and effective”

An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall risk of blood clots with this vaccine.

Views & Analysis

Pharma sales rep talking to a GP over video conferencing

How COVID-19 has changed the role of pharma sales reps

The demise of the pharmaceutical sales representative has been greatly exaggerated over the years.

News

GSK and Medicago's plant-based COVID shot heads into phase 3

At the start of the pandemic GlaxoSmithKline made its vaccine booster tech available looking for collaborations with other vaccine developers – but GSK has been lagging behind rivals like P

News

IBM-led group wins German contract for digital vaccine passp...

Germany has awarded a tender to a consortium led by IBM to develop a secure app that will provide a digital version of the country’s paper vaccine certificates.

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

States halting AZ jab a ‘disaster’ for EU’s COVID vaccinatio...

The decision by around a dozen EU countries to suspend dosing with AstraZeneca’s COVID-19 vaccine is facing criticism, amid fears that it could undermine the response to the pandemic in Eur

R&D

The host immune response in COVID-19 and beyond

MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies.

EMA review finds AZ COVID-19 vaccine “safe and effective”

How COVID-19 has changed the role of pharma sales reps

GSK and Medicago's plant-based COVID shot heads into phase 3

IBM-led group wins German contract for digital vaccine passp...

States halting AZ jab a ‘disaster’ for EU’s COVID vaccinatio...

The host immune response in COVID-19 and beyond

Trial miss doesn't dent Biogen's faith in Alzheimer's drug

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks